Better Therapeutics Inc (NQ: BTTX )
0.7500 +0.0272 (+3.76%) Streaming Delayed Price Updated: 10:11 AM EDT, Jun 2, 2023 Add to My Watchlist
Headline News about Better Therapeutics Inc
Better Therapeutics: Q1 Earnings Insights
May 11, 2023
Better Therapeutics's Earnings: A Preview
May 10, 2023
A Preview Of Better Therapeutics's Earnings
March 29, 2023
Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes
September 22, 2022
12 Health Care Stocks Moving In Friday's Intraday Session
April 07, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
April 06, 2023
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...
Bridgeline Digital And 2 Other Penny Stocks Insiders Are Aggressively Buying
September 16, 2022
The Nasdaq 100 dropped by more than 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public...
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 02, 2022
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...
Better Therapeutics' Shares Shoot Higher Following Positive Results From Type 2 Diabetes Study
July 28, 2022
Better Therapeutics (NASDAQ: BTTX) announced positive results from its pivotal clinical trial for BT-001, prescription digital therapeutic that is designed to use nCBT to treat c diabetes (T2D).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following